NCNA - ニュ―カナ (NuCana plc)

NCNAのニュース

   NuCana plc (NASDAQ:NCNA) Short Interest Down 73.1% in October  2020/11/17 16:34:57 Transcript Daily
NuCana plc (NASDAQ:NCNA) saw a significant decrease in short interest in the month of October. As of October 30th, there was short interest totalling 149,000 shares, a decrease of 73.1% from the October 15th total of 553,700 shares. Based on an average trading volume of 229,200 shares, the days-to-cover ratio is presently 0.7 days. Approximately […]
   NuCana (NASDAQ:NCNA) Stock Price Up 9.9%  2020/10/24 11:30:42 Stock Observer
Shares of NuCana plc (NASDAQ:NCNA) shot up 9.9% during trading on Thursday . The stock traded as high as $5.78 and last traded at $5.56. 258,157 shares traded hands during trading, an increase of 71% from the average session volume of 151,257 shares. The stock had previously closed at $5.06. A number of analysts recently […]
   NuCana plc (NASDAQ:NCNA) Receives Average Rating of “Buy” from Brokerages  2020/10/24 00:30:46 US Banking News
NuCana plc (NASDAQ:NCNA) has been assigned an average rating of “Buy” from the nine ratings firms that are presently covering the firm, MarketBeat.com reports. Three research analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 1-year price target among brokers that have issued […]
   NuCana plc (NASDAQ:NCNA) Given Average Recommendation of “Buy” by Brokerages  2020/10/23 22:30:43 Daily Political
NuCana plc (NASDAQ:NCNA) has received an average recommendation of “Buy” from the nine brokerages that are currently covering the firm, Marketbeat reports. Three research analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 1 year price objective among analysts that have covered the […]
   NuCana (NASDAQ:NCNA) Raised to Hold at Zacks Investment Research  2020/10/21 09:48:42 Zolmax News
NuCana (NASDAQ:NCNA) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Wednesday, Zacks.com reports. According to Zacks, “NuCana PLC is a clinical-stage biopharmaceutical company. It focused on improving treatment outcomes for cancer patients by applying its phosphoramidate chemistry technology. The company’s pipeline of products includes […]
   NuCana plc (NASDAQ:NCNA) Short Interest Down 73.1% in October  2020/11/17 16:34:57 Transcript Daily
NuCana plc (NASDAQ:NCNA) saw a significant decrease in short interest in the month of October. As of October 30th, there was short interest totalling 149,000 shares, a decrease of 73.1% from the October 15th total of 553,700 shares. Based on an average trading volume of 229,200 shares, the days-to-cover ratio is presently 0.7 days. Approximately […]
   NuCana (NASDAQ:NCNA) Stock Price Up 9.9%  2020/10/24 11:30:42 Stock Observer
Shares of NuCana plc (NASDAQ:NCNA) shot up 9.9% during trading on Thursday . The stock traded as high as $5.78 and last traded at $5.56. 258,157 shares traded hands during trading, an increase of 71% from the average session volume of 151,257 shares. The stock had previously closed at $5.06. A number of analysts recently […]
   NuCana plc (NASDAQ:NCNA) Receives Average Rating of “Buy” from Brokerages  2020/10/24 00:30:46 US Banking News
NuCana plc (NASDAQ:NCNA) has been assigned an average rating of “Buy” from the nine ratings firms that are presently covering the firm, MarketBeat.com reports. Three research analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 1-year price target among brokers that have issued […]
   NuCana plc (NASDAQ:NCNA) Given Average Recommendation of “Buy” by Brokerages  2020/10/23 22:30:43 Daily Political
NuCana plc (NASDAQ:NCNA) has received an average recommendation of “Buy” from the nine brokerages that are currently covering the firm, Marketbeat reports. Three research analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 1 year price objective among analysts that have covered the […]
   NuCana (NASDAQ:NCNA) Raised to Hold at Zacks Investment Research  2020/10/21 09:48:42 Zolmax News
NuCana (NASDAQ:NCNA) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Wednesday, Zacks.com reports. According to Zacks, “NuCana PLC is a clinical-stage biopharmaceutical company. It focused on improving treatment outcomes for cancer patients by applying its phosphoramidate chemistry technology. The company’s pipeline of products includes […]
   NuCana plc (NASDAQ:NCNA) Short Interest Down 73.1% in October  2020/11/17 16:34:57 Transcript Daily
NuCana plc (NASDAQ:NCNA) saw a significant decrease in short interest in the month of October. As of October 30th, there was short interest totalling 149,000 shares, a decrease of 73.1% from the October 15th total of 553,700 shares. Based on an average trading volume of 229,200 shares, the days-to-cover ratio is presently 0.7 days. Approximately […]
   NuCana (NASDAQ:NCNA) Stock Price Up 9.9%  2020/10/24 11:30:42 Stock Observer
Shares of NuCana plc (NASDAQ:NCNA) shot up 9.9% during trading on Thursday . The stock traded as high as $5.78 and last traded at $5.56. 258,157 shares traded hands during trading, an increase of 71% from the average session volume of 151,257 shares. The stock had previously closed at $5.06. A number of analysts recently […]
   NuCana plc (NASDAQ:NCNA) Receives Average Rating of “Buy” from Brokerages  2020/10/24 00:30:46 US Banking News
NuCana plc (NASDAQ:NCNA) has been assigned an average rating of “Buy” from the nine ratings firms that are presently covering the firm, MarketBeat.com reports. Three research analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 1-year price target among brokers that have issued […]
   NuCana plc (NASDAQ:NCNA) Given Average Recommendation of “Buy” by Brokerages  2020/10/23 22:30:43 Daily Political
NuCana plc (NASDAQ:NCNA) has received an average recommendation of “Buy” from the nine brokerages that are currently covering the firm, Marketbeat reports. Three research analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 1 year price objective among analysts that have covered the […]
   NuCana (NASDAQ:NCNA) Raised to Hold at Zacks Investment Research  2020/10/21 09:48:42 Zolmax News
NuCana (NASDAQ:NCNA) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Wednesday, Zacks.com reports. According to Zacks, “NuCana PLC is a clinical-stage biopharmaceutical company. It focused on improving treatment outcomes for cancer patients by applying its phosphoramidate chemistry technology. The company’s pipeline of products includes […]

calendar